The global embolotherapy market is expected to grow at a CAGR of 6.8% during the forecast period with its market size predicted was at USD 3.6 billion by 2030. Globally, embolotherapy industry players are undertaking considerable investment decisions and launching new products in order gain competitive advantage. Moreover, entering into partnership agreements and performing mergers & acquisitions are the key development strategies being implemented by the crucial players in global embolotherapy market.
Hospital and clinics category held largest share in the embolotherapy market in 2022
Based on end user, the global embolotherapy market is segmented into ambulatory surgical centers (ASCs), hospitals and clinics, and others. Amongst these segments, hospitals and clinics are dominating in terms of revenue throughout the estimated period owing to extensive accessibility of reimbursements policies being implemented by hospitals and clinics and excessive adoption of these devices in small clinics, big hospitals and critical care units.
Browse Market Insight and In-depth TOC on "Global Embolotherapy Market - Analysis and Forecast (2023-2030)"
North America has accounted for the largest share in embolotherapy market, globally and is predicted to grow significantly during the forecast period, owing to the increasing emphasis in the region towards development of advanced embolic agents, extensive pervasiveness of incidents that necessitates adoption of embolization processes. Moreover, established healthcare system in this region is the key factor that is further anticipated to drive the growth of embolotherapy market in this region.
Some of the players having prominent presence in the global embolotherapy market include Merit Medical Systems, Acandis GmbH, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Terumo Corporation, Stryker Corporation, Johnson & Johnson, BALT Extrusion, Sirtex Medical Limited, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Penumbra, Inc., and BTG Plc.
Key Takeaway from the Report:
The Report Offers:
Benefits of Report Purchase from VynZ:
We provide accurate data and in-depth analysis with all-inclusive coverage.
Robust Research Methodology
Robust research methodology and data triangulation to ensure high quality report.
24*7 analyst support – Pre and post purchase of the report as well as during the project tenure.
24*7 sales support – Hassle free delivery of the report and quick response and support by sales team.
20% post purchase free customization to meet your requirements.
We claim full customer satisfaction as our core values lie in building long term relationship.
High level of data security and confidentiality of your information.
The report provides the market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue (USD Million) and Volume (Unit). The report segments the global embolotherapy market on the basis of product, procedure, indication, end user, and region.
Global Embolotherapy Market Coverage
Product Insight and Forecast 2018-2030
Procedure Insight and Forecast 2018-2030
Indication Insight and Forecast 2018-2030
End User Insight and Forecast 2018-2030
Embolotherapy Market by Region
Rest of the World (RoW)